
Bioorganic and Medicinal Chemistry Letters p. 1019 - 1022 (1998)
Update date:2022-08-05
Topics:
Sasaki, Shigeki
Hashimoto, Tomohiro
Obana, Norihiro
Yasuda, Hideyo
Uehara, Yoshimasa
Maeda, Minoru
New inhibitors have been designed for cdc2 kinase based on a multiple pseudosubstrate structure. The new inhibitors have three different structural components: 3,4-bis(indol-3-yl)maleimide, Ac-Cys-(Ser)-Pro-Lys-Lys-NHMe, and ethyloxy group between the two components. Inhibitory activities toward cdc2 and other protein kinases were investigated, and the compound (21) with Ac- Cys-Pro-Lys-Lys-NHMe connected with the triethylene glycol spacer exhibited the most potent inhibition with relatively high selectivity.
View MoreContact:+86 021-51698675
Address:1701, Jielong Plaza, No.618 Pingliang Rd, ShangHai,China
AUSHUN PHARMACEUTICAL TECHNOLOGY CO,.LTD
Contact:+86-25-86883560 15951806178
Address:14 Dayingbi, Zhujiang Rd. East, Nanjing, Jiangsu, China.
Fuxin Jintelai Fluorin Chemical Co., Ltd.
Contact:+86-0418-8229599
Address:, 7th Huagong Road, Fluorine industry development zone (Yimatu Town,Fumeng County),Fuxin City, Liaoning Province, China
MOKESI TECHNOLOGY CO., LIMITED
Contact:000000000000
Address:NO.168 ,Weisi Road, Zhengzhou City,Henan,China
WUXI KINGHAN BIO-MEDICAL&CHEMICAL INC.
Contact:13861062998
Address:Room 1316,No.1619 Huishan Avenue,Wuxi,China
Doi:10.1021/ic020375g
(2002)Doi:10.1016/S0277-5387(97)00376-8
(1998)Doi:10.1016/S0040-4039(00)72793-6
(1968)Doi:10.1016/S0040-4039(00)71266-4
(1991)Doi:10.1039/j39680002947
(1968)Doi:10.1016/S0957-4166(97)00128-6
(1997)